| dc.date.accessioned | 2021-03-08T15:55:31Z | |
| dc.date.available | 2021-03-08T15:55:31Z | |
| dc.date.issued | 2020-12-03 | |
| dc.identifier.uri | https://soundcloud.com/bmjpodcasts/covid-19-and-comorbidities | en_US |
| dc.identifier.uri | https://hdl.handle.net/20.500.12663/2507 | |
| dc.description.abstract | A recent meta-analysis by Espinosa and colleagues, “Prevalence of Comorbidities in Patients and Mortality Cases Affected by SARS-CoV2”, found that 42% of patients with Covid-19 had comorbidities. Furthermore, 61% of those with Covid-19 admitted to the Intensive Care Unit had comorbidities, and 77% of those who died had comorbidities. Hypertension was the most prevalent comorbidity (affecting 32% of patients). Other common comorbidities included diabetes (22%), heart disease (13%), and COPD (8%). | en_US |
| dc.language | English | en_US |
| dc.subject | COVID-19 | en_US |
| dc.subject | Comorbidity | en_US |
| dc.subject | SARS-CoV-2 | en_US |
| dc.subject | Betacoronavirus | en_US |
| dc.subject | Coronavirus | en_US |
| dc.subject | Coronavirus Infections | en_US |
| dc.subject | Infectious Diseases | en_US |
| dc.subject | Mortality | en_US |
| dc.title | Covid-19 and comorbidities | en_US |
| eihealth.country | Others | en_US |
| eihealth.category | Health systems and services | en_US |
| eihealth.category | Operation readiness, surge capacity | en_US |
| eihealth.type | Other publications | en_US |
| eihealth.maincategory | Save Lives / Salvar Vidas | en_US |
| dc.relation.ispartofjournal | BMJ talk medicine | en_US |
| dc.contributor.corporatename | BMJ Best Practice | en_US |
